Preferences in traumatic intracranial hemorrhage: bleeding vs. clotting
- PMID: 20497598
- PMCID: PMC2911700
- DOI: 10.1186/cc8996
Preferences in traumatic intracranial hemorrhage: bleeding vs. clotting
Abstract
Patients with traumatic brain injury and resultant intracranial hemorrhage (ICH) are at high risk for developing venous thromboembolism (VTE). The use of thromboprophylaxis is effective at decreasing the rate of VTE, but at the potential expense of an increased risk of ICH progression. Physicians must carefully consider both the benefits and risks of VTE prophylaxis before prescribing chemical anticoagulants to these patients. To help clarify this difficult choice, Scales and colleagues performed a decision analysis to determine whether the benefits of thromboprophylaxis outweigh the potential risk of worsening ICH. There is increasing evidence that bleeding risks are not as prominent as previously thought. Although the results were largely inconclusive, the present study has identified areas for future research.
Comment on
-
Prophylactic anticoagulation to prevent venous thromboembolism in traumatic intracranial hemorrhage: a decision analysis.Crit Care. 2010;14(2):R72. doi: 10.1186/cc8980. Epub 2010 Apr 20. Crit Care. 2010. PMID: 20406444 Free PMC article.
Similar articles
-
Prophylactic anticoagulation to prevent venous thromboembolism in traumatic intracranial hemorrhage: a decision analysis.Crit Care. 2010;14(2):R72. doi: 10.1186/cc8980. Epub 2010 Apr 20. Crit Care. 2010. PMID: 20406444 Free PMC article.
-
Chemical venous thromboembolic prophylaxis is safe and effective for patients with traumatic brain injury when started 24 hours after the absence of hemorrhage progression on head CT.J Trauma Acute Care Surg. 2012 Aug;73(2):426-30. doi: 10.1097/TA.0b013e31825a758b. J Trauma Acute Care Surg. 2012. PMID: 22846950
-
Newer and Better? Comparing Direct Oral Anticoagulants to Warfarin in Patients With Traumatic Intracranial Hemorrhage.Am Surg. 2020 Sep;86(9):1062-1066. doi: 10.1177/0003134820942204. Epub 2020 Aug 16. Am Surg. 2020. PMID: 33049165
-
Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.Thromb Haemost. 2015 Feb;113(2):231-46. doi: 10.1160/TH14-06-0484. Epub 2014 Oct 16. Thromb Haemost. 2015. PMID: 25319150 Review.
-
Clinical outcomes following early versus late pharmacologic thromboprophylaxis in patients with traumatic intracranial hemorrhage: a systematic review and meta-analysis.Neurosurg Rev. 2020 Jun;43(3):861-872. doi: 10.1007/s10143-018-1045-y. Epub 2018 Oct 29. Neurosurg Rev. 2020. PMID: 30374758
Cited by
-
Efficacy and Safety of Panax notoginseng Saponin Therapy for Acute Intracerebral Hemorrhage, Meta-Analysis, and Mini Review of Potential Mechanisms of Action.Front Neurol. 2015 Jan 7;5:274. doi: 10.3389/fneur.2014.00274. eCollection 2014. Front Neurol. 2015. PMID: 25620952 Free PMC article.
-
Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty.Vasc Health Risk Manag. 2014 Mar 26;10:157-67. doi: 10.2147/VHRM.S54714. eCollection 2014. Vasc Health Risk Manag. 2014. PMID: 24707185 Free PMC article.
References
-
- Norwood SH, McAuley CE, Berne JD, Vallina VL, Kerns DB, Grahm TW, Short K, McLarty JW. Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries. Arch Surg. 2002;137:696–701. doi: 10.1001/archsurg.137.6.696. discussion 701-692. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources